Arkolith/Insider Trading/BTTX/Form 4

Parker Geoffrey M.

DirectorBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Jun 14, 2022
Net Buying
Open-Market Buys
$36K
Open-Market Sells
$0
Net Open-Market Flow
$36K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2022Buy(P)25K$1.45$36K40K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-022382) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML